Mackenzie Financial »

Monte Rosa Therapeutics shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $575k 78k 7.41
2025-06-30 $350k 78k 4.51

More positions owned by Mackenzie Financial

Rbc Cad (RY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Agnico (AEM)
Shopify Cl A Sub Vtg Shs (SHOP)
Bank Of Montreal Cadcom (BMO)
Canadian Pacific Kansas City (CP)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Waste Connections (WCN)
Meta Platforms Cl A (META)

View all positions for Mackenzie Financial

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Versant Venture Management
Baker Bros. Advisors
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
Aisling Capital Management
Alphabet
Geode Capital Management
Marshall Wace
State Street Corporation
Vestal Point Capital
Northern Trust

View all funds holding Monte Rosa Therapeutics